DK398088A - Anvendelse af 4-amino-6,7-dimethoxy-2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinol-2-yl)quinolin til fremstilling af et laegemiddel til behandling af hjertearrytmier - Google Patents

Anvendelse af 4-amino-6,7-dimethoxy-2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinol-2-yl)quinolin til fremstilling af et laegemiddel til behandling af hjertearrytmier

Info

Publication number
DK398088A
DK398088A DK398088A DK398088A DK398088A DK 398088 A DK398088 A DK 398088A DK 398088 A DK398088 A DK 398088A DK 398088 A DK398088 A DK 398088A DK 398088 A DK398088 A DK 398088A
Authority
DK
Denmark
Prior art keywords
dimethoxy
tetrahydroisoquinol
amino
arrhythmias
cartric
Prior art date
Application number
DK398088A
Other languages
Danish (da)
English (en)
Other versions
DK398088D0 (da
Inventor
Michael John Davey
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of DK398088D0 publication Critical patent/DK398088D0/da
Publication of DK398088A publication Critical patent/DK398088A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK398088A 1987-07-17 1988-07-15 Anvendelse af 4-amino-6,7-dimethoxy-2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinol-2-yl)quinolin til fremstilling af et laegemiddel til behandling af hjertearrytmier DK398088A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878716972A GB8716972D0 (en) 1987-07-17 1987-07-17 Treatment of cardiac arrhythmias

Publications (2)

Publication Number Publication Date
DK398088D0 DK398088D0 (da) 1988-07-15
DK398088A true DK398088A (da) 1989-01-18

Family

ID=10620869

Family Applications (1)

Application Number Title Priority Date Filing Date
DK398088A DK398088A (da) 1987-07-17 1988-07-15 Anvendelse af 4-amino-6,7-dimethoxy-2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinol-2-yl)quinolin til fremstilling af et laegemiddel til behandling af hjertearrytmier

Country Status (21)

Country Link
EP (1) EP0303357B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS6440425A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR930001105B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1019545B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE72976T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU604554B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1330947C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD283931A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3868772D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK398088A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB8716972D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU201244B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE60356B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL87082A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX12192A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY103537A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ225426A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH25873A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT88002B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU137888A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA885092B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1117409E (pt) * 1998-09-10 2005-04-29 Aventis Pharma Gmbh Benzenossulfonil (tio) ureias em associacao com betabloqueantes para o tratamento de disfuncoes do sistema nervoso autonomo
US6339093B1 (en) * 1999-10-08 2002-01-15 Hoffmann-La Roche Inc. Isoquinoline derivatives
CN1328263C (zh) * 2004-11-01 2007-07-25 上海汇伦生命科技有限公司 四氢异喹啉衍生物、其制备方法及药物组合物
WO2015018797A2 (en) * 2013-08-05 2015-02-12 Haplogen Gmbh Antiviral compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79603B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1982-07-24 1984-10-31 Pfizer

Also Published As

Publication number Publication date
CN1019545B (zh) 1992-12-23
YU137888A (sh) 1995-03-27
DD283931A5 (de) 1990-10-31
JPS6440425A (en) 1989-02-10
CN1030871A (zh) 1989-02-08
KR930001105B1 (ko) 1993-02-18
GB8716972D0 (en) 1987-08-26
KR890001552A (ko) 1989-03-27
HU201244B (en) 1990-10-28
PT88002A (pt) 1989-06-30
CA1330947C (en) 1994-07-26
PT88002B (pt) 1995-03-01
DK398088D0 (da) 1988-07-15
IE882172L (en) 1989-01-17
EP0303357B1 (en) 1992-03-04
MX12192A (es) 1993-08-01
DE3868772D1 (de) 1992-04-09
NZ225426A (en) 1991-03-26
ATE72976T1 (de) 1992-03-15
EP0303357A2 (en) 1989-02-15
AU1911088A (en) 1989-01-19
PH25873A (en) 1991-12-02
IE60356B1 (en) 1994-06-29
ZA885092B (en) 1990-02-28
JPH0576925B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-10-25
AU604554B2 (en) 1990-12-20
IL87082A0 (en) 1988-12-30
EP0303357A3 (en) 1990-08-16
MY103537A (en) 1993-07-31
HUT47218A (en) 1989-02-28

Similar Documents

Publication Publication Date Title
HK42781A (en) 4-amino-6,7-dimethoxy-2-(4-(heterocyclocarbonyl)piperozin-1-yl)quinazolines
NO913785D0 (no) Fremgangsmaate for fremstilling av fibrinogenreseptorantagonister.
DE3775527D1 (de) 1,5-diphenylpyrazol-3-carbonsaeurederivate zum schuetzen von kulturpflanzen.
FI882791A7 (fi) Aineita, jotka parantavat määrättyjen 1,4-dihydropyridiinijohdannaisten siirtymistä ihon läpi.
DE3774918D1 (de) Cancerostatisches mittel.
DE69718469D1 (de) Verbindungen mit wachtumshormon freisetzenden eigenschaften
UY26426A1 (es) Nuevos compuestos
DK398088A (da) Anvendelse af 4-amino-6,7-dimethoxy-2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinol-2-yl)quinolin til fremstilling af et laegemiddel til behandling af hjertearrytmier
DE3767287D1 (de) Potenzierung von prazosin.
FR2372825A1 (fr) Derives du bezimidazole et leur utilisation therapeutique comme hypotenseurs
IT8519042A0 (it) Impiego di chinoloni nel trattamento di malattie cardiache.!
TR24967A (tr) DIKOTILEDON TüRüNDEN YABANI OTLARA KARSI ETKILI, HERBISIT OLARAK KULLANILACAK GLIOKSIL-SIKLOHEKSEN- DIONLAR.
ES456280A1 (es) Un procedimiento para la obtencion de alfa-2,5,9-trimetil- benzo(b)tieno(2,3-f)morfano.
DK0428107T3 (da) Anvendelse af quinolyl- og isoquinolyloxazol-2-oner til fremstilling af et lægemiddel til behandling af multidrugresistente tumorer
IT8603587A0 (it) Cannula per aspirazione chirurgica
BE1002099A3 (fr) Nouvelles quinazolinones tetracycliques, leur preparation et leur utilisation comme medicaments.
NO173605C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 4-amino-6,7-dimetoksy-2(6,7-dimetoksy-1,2,3,4-tetrahydroisokinol-2-yl)-kinolin
IE46285L (en) 6, 7-dimethoxy-2-(4-thiomorpholinyl)-4-quinazolinamine¹derivatives
ATE10278T1 (de) Wasserloesliche salze von 2,4-diamino-5-methyl-6((3,4,5-trimethoxyanilino)-methyl)chinazolin, diese salze enthaltende zusammensetzungen und herstellung dieser salze.
NO170545C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 6,21-dimethyl-19-nor-pregna-diener
NO875324D0 (no) Ikke-vevet arbeidsdress med draapeskulder.
IT8721992A0 (it) Metodo ed apparecchiatura per la stiratura del corpo dei pantaloni.
IT8421168V0 (it) Ferro per il trattamento delle callosita'.
IT8419064A0 (it) Procedimento perfezionato per lapreparazione del5-ammino-(3,4'-bipiridin)-6(1h)-one .
ATE94759T1 (de) Verwendung von dextransulfat, gegebenenfalls in kombination mit anti-androgenen mitteln zur behandlung des humanen protatakarzinoms.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment